Essential Role of the Adhesion Receptor LFA-1 for T Cell-Dependent Fulminant Hepatitis
Viral hepatitis affects more than 2 billion people worldwide. In particular, no effective treatment exists to abrogate death and liver damage in fulminant hepatitis. Activation of T cells is an initial and critical event in the pathogenesis of liver damage in autoimmune and viral hepatitis. The prec...
Saved in:
Published in: | The Journal of immunology (1950) Vol. 169; no. 12; pp. 7087 - 7096 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Am Assoc Immnol
15-12-2002
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Viral hepatitis affects more than 2 billion people worldwide. In particular, no effective treatment exists to abrogate death and liver damage in fulminant hepatitis. Activation of T cells is an initial and critical event in the pathogenesis of liver damage in autoimmune and viral hepatitis. The precise molecular mechanisms that induce T cell-mediated hepatocyte injury remain largely unclear. In mice, T cell-dependent hepatitis and acute liver damage can be modeled using ConA. In this study, we examined the role of the adhesion receptor LFA-1 in ConA-induced acute hepatic damage using LFA-1(-/-) (CD11a) mice. Massive liver cell apoptosis and metabolic liver damage were observed in LFA-1(+/+) mice following ConA injection. By contrast, LFA-1(-/-) mice were completely resistant to ConA-induced hepatitis and none of the LFA-1(-/-) mice showed any hepatic damage. Whereas activated hepatic T cells remained in the liver in LFA-1(+/+) mice, activated T cells were rapidly cleared from the livers of LFA-1(-/-) mice. Mechanistically, T cells from LFA-1(-/-) mice showed markedly reduced cytotoxicity toward liver cells as a result of impaired, activation-dependent adhesion. Importantly, adoptive transfer of hepatic T cells from LFA-1(+/+) mice, but not from LFA-1(-/-) mice, sensitized LFA-1(-/-) mice to ConA-induced hepatitis. Thus, LFA-1 expression on T cells is necessary and sufficient for T cell-mediated liver damage in vivo. These results provide the first genetic evidence on an adhesion receptor, LFA-1, that has a crucial role in fulminant hepatitis. These genetic data identify LFA-1 as a potential key target for the treatment of T cell-mediated hepatitis and the prevention of liver damage. |
---|---|
AbstractList | Viral hepatitis affects more than 2 billion people worldwide. In particular, no effective treatment exists to abrogate death and liver damage in fulminant hepatitis. Activation of T cells is an initial and critical event in the pathogenesis of liver damage in autoimmune and viral hepatitis. The precise molecular mechanisms that induce T cell-mediated hepatocyte injury remain largely unclear. In mice, T cell-dependent hepatitis and acute liver damage can be modeled using ConA. In this study, we examined the role of the adhesion receptor LFA-1 in ConA-induced acute hepatic damage using LFA-1 super(-/-) (CD11a) mice. Massive liver cell apoptosis and metabolic liver damage were observed in LFA-1 super(+/+) mice following ConA injection. By contrast, LFA-1 super(-/-) mice were completely resistant to ConA-induced hepatitis and none of the LFA-1 super(-/-) mice showed any hepatic damage. Whereas activated hepatic T cells remained in the liver in LFA-1 super(+/+) mice, activated T cells were rapidly cleared from the livers of LFA-1 super(-/-) mice. Mechanistically, T cells from LFA-1 super(-/-) mice showed markedly reduced cytotoxicity toward liver cells as a result of impaired, activation-dependent adhesion. Importantly, adoptive transfer of hepatic T cells from LFA-1 super(+/+) mice, but not from LFA-1 super(-/-) mice, sensitized LFA-1 super(-/-) mice to ConA-induced hepatitis. Thus, LFA-1 expression on T cells is necessary and sufficient for T cell-mediated liver damage in vivo. These results provide the first genetic evidence on an adhesion receptor, LFA-1, that has a crucial role in fulminant hepatitis. These genetic data identify LFA-1 as a potential key target for the treatment of T cell-mediated hepatitis and the prevention of liver damage. Abstract Viral hepatitis affects more than 2 billion people worldwide. In particular, no effective treatment exists to abrogate death and liver damage in fulminant hepatitis. Activation of T cells is an initial and critical event in the pathogenesis of liver damage in autoimmune and viral hepatitis. The precise molecular mechanisms that induce T cell-mediated hepatocyte injury remain largely unclear. In mice, T cell-dependent hepatitis and acute liver damage can be modeled using ConA. In this study, we examined the role of the adhesion receptor LFA-1 in ConA-induced acute hepatic damage using LFA-1−/− (CD11a) mice. Massive liver cell apoptosis and metabolic liver damage were observed in LFA-1+/+ mice following ConA injection. By contrast, LFA-1−/− mice were completely resistant to ConA-induced hepatitis and none of the LFA-1−/− mice showed any hepatic damage. Whereas activated hepatic T cells remained in the liver in LFA-1+/+ mice, activated T cells were rapidly cleared from the livers of LFA-1−/− mice. Mechanistically, T cells from LFA-1−/− mice showed markedly reduced cytotoxicity toward liver cells as a result of impaired, activation-dependent adhesion. Importantly, adoptive transfer of hepatic T cells from LFA-1+/+ mice, but not from LFA-1−/− mice, sensitized LFA-1−/− mice to ConA-induced hepatitis. Thus, LFA-1 expression on T cells is necessary and sufficient for T cell-mediated liver damage in vivo. These results provide the first genetic evidence on an adhesion receptor, LFA-1, that has a crucial role in fulminant hepatitis. These genetic data identify LFA-1 as a potential key target for the treatment of T cell-mediated hepatitis and the prevention of liver damage. Viral hepatitis affects more than 2 billion people worldwide. In particular, no effective treatment exists to abrogate death and liver damage in fulminant hepatitis. Activation of T cells is an initial and critical event in the pathogenesis of liver damage in autoimmune and viral hepatitis. The precise molecular mechanisms that induce T cell-mediated hepatocyte injury remain largely unclear. In mice, T cell-dependent hepatitis and acute liver damage can be modeled using ConA. In this study, we examined the role of the adhesion receptor LFA-1 in ConA-induced acute hepatic damage using LFA-1(-/-) (CD11a) mice. Massive liver cell apoptosis and metabolic liver damage were observed in LFA-1(+/+) mice following ConA injection. By contrast, LFA-1(-/-) mice were completely resistant to ConA-induced hepatitis and none of the LFA-1(-/-) mice showed any hepatic damage. Whereas activated hepatic T cells remained in the liver in LFA-1(+/+) mice, activated T cells were rapidly cleared from the livers of LFA-1(-/-) mice. Mechanistically, T cells from LFA-1(-/-) mice showed markedly reduced cytotoxicity toward liver cells as a result of impaired, activation-dependent adhesion. Importantly, adoptive transfer of hepatic T cells from LFA-1(+/+) mice, but not from LFA-1(-/-) mice, sensitized LFA-1(-/-) mice to ConA-induced hepatitis. Thus, LFA-1 expression on T cells is necessary and sufficient for T cell-mediated liver damage in vivo. These results provide the first genetic evidence on an adhesion receptor, LFA-1, that has a crucial role in fulminant hepatitis. These genetic data identify LFA-1 as a potential key target for the treatment of T cell-mediated hepatitis and the prevention of liver damage. |
Author | Tone, Daisuke Tsukinoki, Kei-ichi Matsumoto, Goichi Iwamiya, Mariko Oliveira-dos-Santos, Antonio Tsunematsu, Satoshi Penninger, Josef M Ohmi, Yasushi Shindo, Junichi |
Author_xml | – sequence: 1 fullname: Matsumoto, Goichi – sequence: 2 fullname: Tsunematsu, Satoshi – sequence: 3 fullname: Tsukinoki, Kei-ichi – sequence: 4 fullname: Ohmi, Yasushi – sequence: 5 fullname: Iwamiya, Mariko – sequence: 6 fullname: Oliveira-dos-Santos, Antonio – sequence: 7 fullname: Tone, Daisuke – sequence: 8 fullname: Shindo, Junichi – sequence: 9 fullname: Penninger, Josef M |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/12471145$$D View this record in MEDLINE/PubMed |
BookMark | eNpNkE1r3DAURUVJaCYf_yAErUI3nujJsiQvh0mmKQwUQtqtkO3njIJsOZbN0H9fDTOhXb27OPfyOJfkrA89EnILbCmYKB_eXdfNffBLkOUS-FIxrb6QBRQFy6Rk8owsGOM8AyXVBbmM8Z0xJhkXX8kFcKEARLEgv59ixH5y1tOX4JGGlk47pKtmh9GFnr5gjcMURrrdrDKgbUqvdI3eZ484YN-kLt3MvnO9TekZBzu5ycVrct5aH_HmdK_Ir83T6_o52_78_mO92ma1gHzKtFZtkzdcgKwZU0JVZdVUhS55q_OqyllVYlGUSktlCw2s1JIn2upWCV3qOr8i98fdYQwfM8bJdC7W6T3bY5ijAS1BMtAJFEewHkOMI7ZmGF1nxz8GmDn4NJ8-TfJpgJuDz1S7O-3PVYfNv9JJYAK-HYGde9vt3Ygmdtb7hIPZ7_f_b_0FRCyBJA |
CitedBy_id | crossref_primary_10_1016_j_jhep_2005_11_042 crossref_primary_10_1074_jbc_M407190200 crossref_primary_10_3181_0801_RM_15 crossref_primary_10_1111_j_1478_3231_2005_01137_x crossref_primary_10_1016_j_imlet_2013_02_004 crossref_primary_10_1016_j_jcmgh_2020_12_003 crossref_primary_10_1371_journal_pone_0215557 crossref_primary_10_3390_cells9061471 crossref_primary_10_4049_jimmunol_0901221 crossref_primary_10_4049_jimmunol_176_8_4914 crossref_primary_10_1111_liv_12182 crossref_primary_10_1007_s00109_022_02215_1 crossref_primary_10_1189_jlb_0905527 crossref_primary_10_3390_molecules24061087 crossref_primary_10_3389_fvets_2022_960981 crossref_primary_10_1152_ajpgi_00184_2004 crossref_primary_10_2353_ajpath_2007_060690 crossref_primary_10_1177_0023677215572841 crossref_primary_10_1371_journal_pone_0090571 crossref_primary_10_1016_j_surg_2008_05_010 crossref_primary_10_1111_j_1476_5381_2011_01225_x crossref_primary_10_1016_j_taap_2012_11_009 crossref_primary_10_1111_sji_12812 |
Cites_doi | 10.1016/S1359-6101(00)00034-4 10.1002/(SICI)1521-4141(199812)28:12<4105::AID-IMMU4105>3.0.CO;2-8 10.4049/jimmunol.162.9.5094 10.1002/hep.510240338 10.1016/S0952-7915(98)80227-6 10.1016/S1089-3261(05)70117-3 10.1006/excr.1996.0351 10.4049/jimmunol.131.2.611 10.4049/jimmunol.160.12.5781 10.1073/pnas.040566697 10.4049/jimmunol.156.4.1587 10.1084/jem.191.1.105 10.1053/gast.1996.v111.pm8690213 10.4049/jimmunol.162.7.3753 10.4049/jimmunol.159.3.1418 10.1084/jem.183.4.1415 10.4049/jimmunol.159.3.1537 10.1146/annurev.immunol.14.1.207 10.1016/0092-8674(93)90134-C 10.1002/hep.1840210131 10.1172/JCI10613 10.4049/jimmunol.163.1.93 10.4049/jimmunol.166.10.5889 10.1111/j.1600-065X.1999.tb01336.x 10.1093/jnci/53.1.261 10.1016/S0753-3322(99)80096-1 10.1172/JCI115836 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 H94 |
DOI | 10.4049/jimmunol.169.12.7087 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Immunology Abstracts AIDS and Cancer Research Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts Immunology Abstracts |
DatabaseTitleList | AIDS and Cancer Research Abstracts CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1550-6606 |
EndPage | 7096 |
ExternalDocumentID | 10_4049_jimmunol_169_12_7087 12471145 www169_12_7087 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | - 08R 2WC 34G 39C 3O- 53G 55 5GY 5RE 5VS 79B 85S 8RP AALRV AARDX ABEFU ABFLS ABOCM ABPPZ ABPTK ACGFS ACIWK ACNCT ACPRK ADACO ADBBV ADKFC AENEX AETEA AFFNX AFRAH AJYGW ALMA_UNASSIGNED_HOLDINGS BAWUL D0L DIK DU5 E3Z EBS EJD F5P FH7 FRP G8K GJ GX1 IH2 J5H K-O K78 KQ8 L7B MVM MYA NEJ O0- OK1 P0W P2P PQEST PQQKQ R.V RHF RHI RZQ SJN SKT TWZ VH1 WH7 WOQ X X7M XJT YCJ ZA5 ZE2 ZGI ZXP --- -~X .55 .GJ 18M ABCQX ABJNI ACGFO ADNWM AFHIN AFOSN AHWXS AI. AIZAD BTFSW CGR CUY CVF ECM EIF NPM TR2 W8F XSW XTH YHG AAYXX CITATION 7T5 H94 |
ID | FETCH-LOGICAL-c413t-887fd3d2416c00747b9bdb5892f83bb30b9e5597867a58109862d24a8f74898c3 |
ISSN | 0022-1767 |
IngestDate | Fri Oct 25 02:41:05 EDT 2024 Thu Sep 26 18:30:18 EDT 2024 Sat Sep 28 08:33:29 EDT 2024 Tue Nov 10 19:47:59 EST 2020 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c413t-887fd3d2416c00747b9bdb5892f83bb30b9e5597867a58109862d24a8f74898c3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | https://journals.aai.org/jimmunol/article-pdf/169/12/7087/1154033/7087.pdf |
PMID | 12471145 |
PQID | 18616018 |
PQPubID | 23462 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_18616018 crossref_primary_10_4049_jimmunol_169_12_7087 pubmed_primary_12471145 highwire_smallpub1_www169_12_7087 |
ProviderPackageCode | RHF RHI |
PublicationCentury | 2000 |
PublicationDate | 20021215 2002-Dec-15 2002-12-15 |
PublicationDateYYYYMMDD | 2002-12-15 |
PublicationDate_xml | – month: 12 year: 2002 text: 20021215 day: 15 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Journal of immunology (1950) |
PublicationTitleAlternate | J Immunol |
PublicationYear | 2002 |
Publisher | Am Assoc Immnol |
Publisher_xml | – name: Am Assoc Immnol |
References | 2022123116452662700_R26 2022123116452662700_R25 2022123116452662700_R24 2022123116452662700_R23 2022123116452662700_R29 2022123116452662700_R28 2022123116452662700_R27 2022123116452662700_R22 2022123116452662700_R21 2022123116452662700_R20 2022123116452662700_R8 2022123116452662700_R15 2022123116452662700_R7 2022123116452662700_R14 2022123116452662700_R13 2022123116452662700_R9 2022123116452662700_R12 2022123116452662700_R19 2022123116452662700_R18 2022123116452662700_R17 2022123116452662700_R16 2022123116452662700_R11 2022123116452662700_R10 2022123116452662700_R2 2022123116452662700_R1 2022123116452662700_R4 2022123116452662700_R3 2022123116452662700_R6 2022123116452662700_R5 |
References_xml | – ident: 2022123116452662700_R1 doi: 10.1016/S1359-6101(00)00034-4 – ident: 2022123116452662700_R15 doi: 10.1002/(SICI)1521-4141(199812)28:12<4105::AID-IMMU4105>3.0.CO;2-8 – ident: 2022123116452662700_R25 doi: 10.4049/jimmunol.162.9.5094 – ident: 2022123116452662700_R16 doi: 10.1002/hep.510240338 – ident: 2022123116452662700_R18 doi: 10.1016/S0952-7915(98)80227-6 – ident: 2022123116452662700_R2 doi: 10.1016/S1089-3261(05)70117-3 – ident: 2022123116452662700_R6 doi: 10.1006/excr.1996.0351 – ident: 2022123116452662700_R20 doi: 10.4049/jimmunol.131.2.611 – ident: 2022123116452662700_R22 doi: 10.4049/jimmunol.160.12.5781 – ident: 2022123116452662700_R24 doi: 10.1073/pnas.040566697 – ident: 2022123116452662700_R28 doi: 10.4049/jimmunol.156.4.1587 – ident: 2022123116452662700_R9 – ident: 2022123116452662700_R14 doi: 10.1084/jem.191.1.105 – ident: 2022123116452662700_R8 doi: 10.1053/gast.1996.v111.pm8690213 – ident: 2022123116452662700_R26 doi: 10.4049/jimmunol.162.7.3753 – ident: 2022123116452662700_R11 doi: 10.4049/jimmunol.159.3.1418 – ident: 2022123116452662700_R21 doi: 10.1084/jem.183.4.1415 – ident: 2022123116452662700_R13 doi: 10.4049/jimmunol.159.3.1537 – ident: 2022123116452662700_R17 doi: 10.1146/annurev.immunol.14.1.207 – ident: 2022123116452662700_R29 doi: 10.1016/0092-8674(93)90134-C – ident: 2022123116452662700_R7 doi: 10.1002/hep.1840210131 – ident: 2022123116452662700_R10 doi: 10.1172/JCI10613 – ident: 2022123116452662700_R12 doi: 10.4049/jimmunol.163.1.93 – ident: 2022123116452662700_R19 – ident: 2022123116452662700_R27 doi: 10.4049/jimmunol.166.10.5889 – ident: 2022123116452662700_R3 doi: 10.1111/j.1600-065X.1999.tb01336.x – ident: 2022123116452662700_R23 doi: 10.1093/jnci/53.1.261 – ident: 2022123116452662700_R4 doi: 10.1016/S0753-3322(99)80096-1 – ident: 2022123116452662700_R5 doi: 10.1172/JCI115836 |
SSID | ssj0006024 |
Score | 1.8799865 |
Snippet | Viral hepatitis affects more than 2 billion people worldwide. In particular, no effective treatment exists to abrogate death and liver damage in fulminant... Abstract Viral hepatitis affects more than 2 billion people worldwide. In particular, no effective treatment exists to abrogate death and liver damage in... |
SourceID | proquest crossref pubmed highwire |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 7087 |
SubjectTerms | Adoptive Transfer Animals Antibodies, Monoclonal - administration & dosage Antigens - biosynthesis Antigens, Surface Cell Adhesion - genetics Cell Adhesion - immunology Cell Line Chemical and Drug Induced Liver Injury - etiology Chemical and Drug Induced Liver Injury - genetics Chemical and Drug Induced Liver Injury - immunology Chemical and Drug Induced Liver Injury - prevention & control Concanavalin A - toxicity Cytotoxicity, Immunologic - genetics Injections, Intravenous Intercellular Adhesion Molecule-1 - immunology Killer Cells, Natural - immunology Killer Cells, Natural - metabolism Killer Cells, Natural - transplantation Lectins, C-Type Liver - immunology Liver - pathology Lymphocyte Activation - genetics Lymphocyte Activation - immunology Lymphocyte Function-Associated Antigen-1 - biosynthesis Lymphocyte Function-Associated Antigen-1 - genetics Lymphocyte Function-Associated Antigen-1 - physiology Mice Mice, Inbred C57BL Mice, Knockout NK Cell Lectin-Like Receptor Subfamily B Protein Biosynthesis Proteins Receptors, Antigen, T-Cell, alpha-beta - biosynthesis T-Lymphocyte Subsets - immunology T-Lymphocyte Subsets - metabolism T-Lymphocyte Subsets - transplantation |
Title | Essential Role of the Adhesion Receptor LFA-1 for T Cell-Dependent Fulminant Hepatitis |
URI | http://www.jimmunol.org/cgi/content/abstract/169/12/7087 https://www.ncbi.nlm.nih.gov/pubmed/12471145 https://search.proquest.com/docview/18616018 |
Volume | 169 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZoEYgLgvJankaCUxWad5xj1c2qiG2RIEW9WU7sqKtuk4okWvHvmbHz2goEHLhEGyuJNzOf7JnJzHyEvHNyOxSxz6zCK8BByfPQ0qe-CAqZCy8QOkH2-Gt0es7miZ-MX_DHsf-qaRgDXWPl7D9oe3goDMBv0DkcQetw_Cu9JzWWE2Ec_EuXOKiLR-SFwrgYmonqGvzs_eXi0HJ0kmG6f6TWa2ve0eE2mBBiEmRgU8KE62ZVT23YsZrMNJzAChPTyem9_l5mT6ILJ6KBl680V9NI45XWbYm9Yut2K_gKw5ersrq8QZB9cbUaN4o-QKG5UkyJ5qRgwIkM68aw6BqClh5d7mQNjexuC1bdqaG8vbnW--Db4FrfveUHeCIGdse7p621Tz_zxdlyydPkPN0ht11YlTD_c_7x07Bth7br963l8d-aOkuc5eBXc2zbMX1v6d_7KdpeSR-Q-52C6KFByENyS5V75I6hHv2xR-6edEkVj8i3ATIUIUOrggJkaA8Z2kOGashQgAxN6TZk6AAZOkDmMTlbJOnRsdXRbVg5WDKNBdtNIT0JJl2Ya16FLM5kFrDYLZiXZZ6dxQr9TxZGImCOHYMzDFcLVmAHI5Z7T8huWZXqGaGxYJH0fMkiIX2wmZmIRF64SBUg3SJXM2L1wuPXpqsKB28Uhc17YXMQNndcjsKekbe9hHl9JdZrkKzDN5vN1jVvetFzWCLxu5coVdXW3GGhE9oOm5GnRiPjnC7YZo4fPP_jvS_IvRHbL8lu871Vr8hOLdvXGkY_AUgKiGc |
link.rule.ids | 315,782,786,27935,27936 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Essential+Role+of+the+Adhesion+Receptor+LFA-1+for+T+Cell-Dependent+Fulminant+Hepatitis&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Matsumoto%2C+G&rft.au=Tsunematsu%2C+S&rft.au=Tsukinoki%2C+K&rft.au=Ohmi%2C+Y&rft.date=2002-12-15&rft.issn=0022-1767&rft.volume=169&rft.issue=12&rft.spage=7087&rft.epage=7096&rft_id=info:doi/10.4049%2Fjimmunol.169.12.7087&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon |